Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Demonstration of Central Line Hub Contamination Reduction Using a Novel Capping Device

NCT01301300 is registered in ClinicalTrials.gov with Endeavor Health as lead sponsor.

NCT NCT01301300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01301300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Demonstration of Central Line Hub Contamination Reduction Using a Novel Capping Device
Lead sponsor
Endeavor Health
Phase
Phase 1/2
Overall status
Unknown status
Start date
April 30, 2010
Completion date
December 31, 2011
Enrollment
600 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

catheter-related bloodstream infection due to central venous catheter